Point72 Asset Management L.P. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:09 pm Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management L.P. | 496 0.000% |
-1,471,275 (-99.97%) |
Filing |
| 2024-01-02 4:15 pm Purchase |
2023-12-21 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management L.P. | 1,471,771 5.700% |
1,471,771 (New Position) |
Filing |